Search research articles
Contact Us
Filters
Showing results (11-20 of 168) with videos related to
Page
of 17
Sort By:
The Journal of Pediatrics
|
September 3, 2004
Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective
Krister K Boman, Jonas Viksten, Per Kogner, et al.
Cell Cycle (Georgetown, Tex.)
|
June 29, 2010
Medulloblastoma: a disease with disorganized developmental signaling cascades
Ninib Baryawno, Baldur Sveinbjörnsson, Per Kogner, et al.
Epigenetics
|
January 21, 2016
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
Maja Olsson, Stephan Beck, Per Kogner, et al.
Journal of the National Cancer Institute
|
October 7, 2004
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma
Magnus Lindskog, Christian Spenger, Jüri Jarvet, et al.
International Journal of Oncology
|
December 13, 2012
Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma
Susanne Fransson, Frida Abel, Per Kogner, et al.
Cancer Immunology, Immunotherapy : CII
|
October 27, 2007
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
Anna De Geer, Lena-Maria Carlson, Per Kogner, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 5, 2009
Embryonal neural tumours and cell death
John Inge Johnsen, Per Kogner, Ami Albihn, et al.
Oncology Reports
|
July 29, 2003
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts
Frida Ponthan, Magnus Lindskog, Nina Karnehed, et al.
Clinical Nuclear Medicine
|
December 21, 2006
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?
Hans Jacobsson, Per M Hellström, Per Kogner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2013
Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro
Mikhail Burmakin, Yao Shi, Elisabeth Hedström, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 168) with videos related to
Sort By:
Page
of 17
The Journal of Pediatrics
|
September 3, 2004
Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective
Krister K Boman, Jonas Viksten, Per Kogner, et al.
Cell Cycle (Georgetown, Tex.)
|
June 29, 2010
Medulloblastoma: a disease with disorganized developmental signaling cascades
Ninib Baryawno, Baldur Sveinbjörnsson, Per Kogner, et al.
Epigenetics
|
January 21, 2016
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
Maja Olsson, Stephan Beck, Per Kogner, et al.
Journal of the National Cancer Institute
|
October 7, 2004
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma
Magnus Lindskog, Christian Spenger, Jüri Jarvet, et al.
International Journal of Oncology
|
December 13, 2012
Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma
Susanne Fransson, Frida Abel, Per Kogner, et al.
Cancer Immunology, Immunotherapy : CII
|
October 27, 2007
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
Anna De Geer, Lena-Maria Carlson, Per Kogner, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 5, 2009
Embryonal neural tumours and cell death
John Inge Johnsen, Per Kogner, Ami Albihn, et al.
Oncology Reports
|
July 29, 2003
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts
Frida Ponthan, Magnus Lindskog, Nina Karnehed, et al.
Clinical Nuclear Medicine
|
December 21, 2006
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?
Hans Jacobsson, Per M Hellström, Per Kogner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2013
Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro
Mikhail Burmakin, Yao Shi, Elisabeth Hedström, et al.
Page
of 17